XBIT

XBiotech Inc.

Price

$2.24

return (12m)

-21.40%

p/e

-1.69

p/bv

0.50

DIVIDEND YIELD

0.00%

XBIT price

XBiotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XBIT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.61%

3 months

-12.16%

1 year

-21.40%

2 years

-69.32%

5 years

-86.01%

10 years

-83.86%

Fundamentals XBIT

Valuation

P/E

-1.69

Sector -4.01

Industry -4.01

P/BV

0.50

Sector 2.04

Industry 2.04

P/Revenue (PSR)

Sector -4.27

Industry -4.27

EV/EBITDA

-13,271,461.82

Sector -238.24

Industry -238.24

EV/EBIT

-12,445,033.80

Sector -670.52

Industry -670.52

P/EBITDA

-1.77

Sector -4.23

Industry -4.23

P/EBIT

-1.70

Sector -4.26

Industry -4.26

P/Total Assets

0.49

Sector 1.45

Industry 1.45

P/Net Current Assets

605,453.09

Sector -13.26

Industry -13.26

P/Working Capital

595,791.32

Sector -11.36

Industry -11.36

EPS

-1.34

Sector -2.20

Industry -2.20

BVPS

4.50

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.28%

Industry 36.28%

EBITDA Margin

Sector -16,823.42%

Industry -16,823.42%

EBIT Margin

Sector -4,238,733.37%

Industry -4,238,733.37%

Operating Margin

0.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

0.00%

Sector -39.92%

Industry -39.92%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-29.74%

Sector -65.94%

Industry -65.94%

ROA

-28.72%

Sector -66.10%

Industry -66.10%

ROIC

-98.23%

Sector -2,918.74%

Industry -2,918.74%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

39.02

Sector 2.90

Industry 2.90

Net Debt / EBITDA

22.55

Sector -13,526,126.10

Industry -13,526,126.10

Net Debt / EBIT

21.15

Sector -3.64

Industry -3.64

Net Debt / Equity

-0.86

Sector -1.10

Industry -1.10

Gross Debt / Equity

0.00

Sector -0.10

Industry -0.10

Equity/Assets

0.97

Sector 0.42

Industry 0.42

Liabilities/Assets

0.03

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

18.18%

Sector -

Industry -

Fundamentals XBIT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
XBIT	-1.69	0.50	-29.74%	0.00%	$67.95 M	0.00%
JNJ	29.55	7.32	24.76%	2.03%	$621.61 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XBIT Historical Dividends

current DY: 0.00%

5-year average DY: 4.46%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/14/2021	07/23/2021	2.50000000

ABOUT XBiotech

XBiotech Inc.

Average Investor10 user rating

4.0 (1 people)

United States

21 years

Founded: 2005

2015

Time since IPO - 11 years

91

Employees

XBiotech Inc. (United States) is listed on the Nasdaq and has a market capitalization of $67.95 million, with shareholders equity totaling $135.02 .

The company employs approximately 91 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, XBiotech Inc. reported $- in revenue, generating net income of $-40.16 .

Key financial metrics include a P/E ratio of -1.69, a price-to-book (P/B) ratio of 0.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XBIT.

Market cap

$67.95 million

Net worth

$135.02

Assets

$139.84

Total Shares Outstanding

30.00

000

Average Daily Trading Volume

$35.13 Thousand

$35,131.16

Sector

Health Care

Industry

Biotechnology

XBIT

XBIT revenue and profits

Financial Results XBIT

DRAG THE FRAME TO SEE MORE DATA

XBIT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$258.25 58,21% (12M)

P/E

29.55

2.03%

ROE

24.76%

P/BV

7.32

MTP - Midatech Pharma

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-10,615.69%

P/BV

0.01

ARGX - argenx

$855.00 26,89% (12M)

P/E

6.07

0.00%

ROE

101.41%

P/BV

6.15

PPD - PPD

$- -0,00% (12M)

P/E

47.29

0.00%

ROE

-84.64%

P/BV

-40.03

ALNY - Alnylam Pharmaceuticals

$203.44 --49,37% (12M)

P/E

ROE

P/BV

GLPG - Galapagos NV

$- -0,00% (12M)

P/E

4.50

0.00%

ROE

10.31%

P/BV

0.46

BGNE - BeiGene

$- -0,00% (12M)

P/E

-22.41

0.00%

ROE

-25.04%

P/BV

5.61